Correspondence 0001213900-22-080075 from China Jo-Jo Drugstores Holdings, Inc. (CJJD) (CIK 0001856084) (RDGT)
China Jo-Jo Drugstores Holdings, Inc. (CJJD) (CIK 0001856084)
Date: Dec. 15, 2022 · CIK: 0001856084 · Accession: 0001213900-22-080075
AI Filing Summary & Sentiment
File numbers found in text: 333-259692
Letter
VIA EDGAR Division of Corporation Finance Office of Trade and Services Attention: Brian Fetterolf Re: China Jo-Jo Drugstores, Inc. Registration Statement on Form F-3, as amended File No. 333-259692
Dear Mr. Fetterolf:
China Jo-Jo Drugstores, Inc. (the “Company”) hereby requests that the above-captioned registration statement (the “Registration Statement”) be declared effective at 4:00 p.m., Eastern Time on Monday, December 19, 2022, or as soon thereafter as may be practicable.
We acknowledge that a declaration by the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, that the Registration Statement is effective does not foreclose the Commission from taking any action with respect to the Registration Statement. We further acknowledge that such a declaration of effectiveness does not relieve the Company from our full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement. We understand that we may not assert staff comments to the Registration Statement or the declaration of effectiveness by the Commission as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If you have any questions, please do not hesitate to contact the undersigned at frank.zhao@jojodrugstores.com, or Elizabeth F. Chen of Pryor Cashman LLP, outside counsel to the Company, at echen@pryorcashman.com (Tel: 212-326-0199).
Very truly yours,
/s/ Ming Zhao
Show Raw Text
CORRESP
1
filename1.htm
China Jo-Jo Drugstores, Inc.
Hai Wai Hai Tongxin Mansion Floor 6
Gong Shu District, Hangzhou City
People’s Republic of China 310008
December
15, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Trade and Services
100 F Street, NE
Washington, D.C. 20549
Attention: Brian Fetterolf
Re: China Jo-Jo Drugstores, Inc.
Registration Statement on Form F-3, as amended
File No. 333-259692
Dear Mr. Fetterolf:
China Jo-Jo Drugstores, Inc.
(the “Company”) hereby requests that the above-captioned registration statement (the “Registration Statement”)
be declared effective at 4:00 p.m., Eastern Time on Monday, December 19, 2022, or as soon thereafter as may be practicable.
We acknowledge that a declaration
by the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, that the
Registration Statement is effective does not foreclose the Commission from taking any action with respect to the Registration Statement.
We further acknowledge that such a declaration of effectiveness does not relieve the Company from our full responsibility for the adequacy
and accuracy of the disclosure in the Registration Statement. We understand that we may not assert staff comments to the Registration
Statement or the declaration of effectiveness by the Commission as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United States.
If you have any questions,
please do not hesitate to contact the undersigned at frank.zhao@jojodrugstores.com, or Elizabeth F. Chen of Pryor Cashman LLP, outside
counsel to the Company, at echen@pryorcashman.com (Tel: 212-326-0199).
Very truly yours,
/s/ Ming Zhao
Ming Zhao
Chief Financial Officer
cc: Elizabeth Fei Chen, Esq.